| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 61,666 | 54,368 | | Cost of Revenue | 25,040 | 26,239 | | | Gross Profit | 36,626 | 28,129 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 31,966 | 22,620 | | Non Recurring |
-
|
-
| | Others | 5,638 | 1,006 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (978) | 4,503 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | (1,374) | 4,503 | | Interest Expense | 2,004 | 1,857 | | Income Before Tax | (3,378) | 2,646 | | Income Tax Expense | (1,270) | 380 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (2,108) | 2,266 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (2,108) | 2,266 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,108) | $2,266 |
|
1.48% Nasdaq 
Income Statement
